A detailed history of Banque Pictet & Cie Sa transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 104,792 shares of ARWR stock, worth $2.01 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
104,792
Previous 108,053 3.02%
Holding current value
$2.01 Million
Previous $3.09 Million 11.88%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$21.87 - $28.24 $71,318 - $92,090
-3,261 Reduced 3.02%
104,792 $2.72 Million
Q1 2024

May 06, 2024

SELL
$27.21 - $39.48 $279,174 - $405,064
-10,260 Reduced 8.67%
108,053 $3.09 Million
Q4 2023

Feb 09, 2024

SELL
$21.2 - $31.03 $283,783 - $415,367
-13,386 Reduced 10.16%
118,313 $3.62 Million
Q3 2023

Nov 02, 2023

SELL
$26.2 - $36.08 $163,199 - $224,742
-6,229 Reduced 4.52%
131,699 $3.54 Million
Q2 2023

Aug 04, 2023

SELL
$25.16 - $41.38 $805,774 - $1.33 Million
-32,026 Reduced 18.84%
137,928 $4.92 Million
Q1 2023

May 01, 2023

SELL
$23.68 - $38.51 $540,046 - $878,259
-22,806 Reduced 11.83%
169,954 $4.32 Million
Q4 2022

Feb 06, 2023

SELL
$28.0 - $40.56 $270,900 - $392,418
-9,675 Reduced 4.78%
192,760 $0
Q3 2022

Nov 10, 2022

BUY
$29.63 - $48.31 $508,480 - $829,047
17,161 Added 9.26%
202,435 $6.69 Billion
Q2 2022

Aug 08, 2022

BUY
$27.79 - $50.61 $480,878 - $875,755
17,304 Added 10.3%
185,274 $6.52 Million
Q1 2022

May 04, 2022

BUY
$39.62 - $69.97 $34,865 - $61,573
880 Added 0.53%
167,970 $7.73 Million
Q4 2021

Feb 02, 2022

BUY
$58.09 - $82.51 $8.58 Million - $12.2 Million
147,631 Added 758.68%
167,090 $11.1 Million
Q3 2021

Nov 10, 2021

BUY
$58.38 - $84.96 $364,758 - $530,830
6,248 Added 47.29%
19,459 $1.22 Million
Q2 2021

Aug 12, 2021

BUY
$62.15 - $90.32 $38,968 - $56,630
627 Added 4.98%
13,211 $1.09 Million
Q1 2021

May 11, 2021

BUY
$61.35 - $90.47 $772,028 - $1.14 Million
12,584 New
12,584 $834,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.03B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.